Predominant p53 mutations in enzootic bovine leukemic cell lines

Area of Science:

• Veterinary Oncology
• Molecular Biology
• Genetics

Background:

• The p53 tumor suppressor gene plays a critical role in preventing cancer.
• Bovine lymphosarcomas, including enzootic bovine leukosis (EBL), are significant neoplastic diseases in cattle.
• Understanding p53 gene alterations in EBL is essential for disease pathogenesis research.

Purpose of the Study:

• To investigate the presence and nature of p53 gene alterations in bovine leukemic cell lines.
• To determine the potential role of p53 mutations in the development of enzootic bovine leukosis (EBL).

Main Methods:

• Amplification and sequencing of the bovine wild-type p53 gene using polymerase chain reaction (PCR).
• Southern blot analysis to detect somatic alterations in p53.
• Northern blot analysis to assess p53-specific transcript expression.
• Reverse transcriptase-PCR (RT-PCR) to identify point mutations in the p53 gene.

Main Results:

• The bovine wild-type p53 gene was successfully amplified and sequenced, showing homology with other species.
• No significant somatic alterations in the p53 gene were detected by Southern blot in eight bovine leukemic cell lines.
• p53-specific transcripts (2.5 kb) were expressed in these cell lines.
• Three missense point mutations in the 'hotspots' of the p53 gene were identified in four of the leukemic cell lines using RT-PCR.

Conclusions:

• p53 gene mutations are prevalent in bovine leukemia virus (BLV)-transformed cell lines.
• These p53 mutations are likely necessary for the pathogenesis of enzootic bovine leukosis (EBL).
• The findings highlight the critical role of p53 in EBL development.